Anonymous
Not logged in
Talk
Contributions
Create account
Log in
Search
Editing
Sonya Marshall-Gradisnik
(section)
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Namespaces
Page
Discussion
More
More
Page actions
Read
Edit
Edit source
History
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Notable studies== *2022, Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients<ref name="Eaton2022">{{Cite journal | title = Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients | date = 2022-02-16|url=https://doi.org/10.1186/s12967-022-03297-8|journal=Journal of Translational Medicine|volume=20|issue=1 | pages = 94 | last = Eaton-Fitch | first = Natalie | authorlink = Natalie Eaton-Fitch | last2 = Du Preez | first2 = Stanley | author-link2 = | last3 = Cabanas | first3=Hélène | authorlink3 = Hélène Cabanas | last4 = Muraki | first4 = Katsuhiko | authorlink4 = | last5 = Staines | first5 = Donald | author-link5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik|doi=10.1186/s12967-022-03297-8|pmc=PMC8848670|pmid=35172836|access-date=|issn=1479-5876|quote=|via=}}</ref> - [https://dx.doi.org/10.1186/s12967-022-03297-8 (Full text)] *2022, Volumetric differences in hippocampal subfields and associations with clinical measures in myalgic encephalomyelitis/chronic fatigue syndrome<ref name="M2022">{{Cite journal | title = Volumetric differences in hippocampal subfields and associations with clinical measures in myalgic encephalomyelitis/chronic fatigue syndrome | date = Jul 2022|url=https://onlinelibrary.wiley.com/doi/10.1002/jnr.25048|journal=Journal of Neuroscience Research|volume=100|issue=7|pages=1476–1486 | last = Thapaliya | first = Kiran | author-link = | last2 = Staines | first2 = Donald | author-link2 = Donald Staines | last3 = Marshall‐Gradisnik | first3 = Sonya | authorlink3 = Sonya Marshall-Gradisnik | last4 = Su | first4 = Jiasheng | authorlink4 = | last5 = Barnden | first5 = Leighton | authorlink5 = Leighton Barnden|language=en|doi=10.1002/jnr.25048|pmc=PMC9321967|pmid=35355311|access-date=|issn=0360-4012|quote=|via=}}</ref> - [https://dx.doi.org/10.1002/jnr.25048 (Full text)] *2022, Alteration of Cortical Volume and Thickness in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref name="Mb2022">{{Cite journal | title = Alteration of Cortical Volume and Thickness in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | date = 2022 | url=https://www.frontiersin.org/articles/10.3389/fnins.2022.848730|journal=Frontiers in Neuroscience|volume=16|issue=|pages = | last = Thapaliya | first = Kiran | author-link = | last2 = Marshall-Gradisnik | first2 = Sonya | authorlink2 = Sonya Marshall-Gradisnik | last3 = Staines | first3=Donald | authorlink3 = Donald Staines | last4 = Su | first4 = Jiasheng | authorlink4 = | last5 = Barnden | first5 = Leighton | authorlink5 = Leighton Barnden|doi=10.3389/fnins.2022.848730|pmc=PMC9072664|pmid=35527811|access-date=|issn=1662-453X|quote=|via=}}</ref> - [https://dx.doi.org/10.3389/fnins.2022.848730 (Full text)] *2021, Potential implications of mammalian transient receptor potential melastatin 7 in the pathophysiology of myalgic encephalomyelitis/chronic fatigue syndrome: A review<ref name="DuPreez2021m">{{Cite journal | title = Potential Implications of Mammalian Transient Receptor Potential Melastatin 7 in the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Review | date = Jan 2021|url=https://www.mdpi.com/1660-4601/18/20/10708|journal=International Journal of Environmental Research and Public Health|volume=18|issue=20|pages=10708 | last = Du Preez | first = Stanley | author-link = | last2 = Cabanas | first2 = Helene | author-link2 = Hélène Cabanas | last3 = Staines | first3=Donald | authorlink3 = Donald Staines | last4 = Marshall-Gradisnik | first4 = Sonya | authorlink4 = Sonya Marshall-Gradisnik|language=en|doi=10.3390/ijerph182010708|pmc=PMC8535478|pmid=34682454|access-date=|issn=1660-4601|quote=|via=}}</ref> - [https://dx.doi.org/10.3390/ijerph182010708 (Full text)] *2021, Network analysis of symptoms co-occurrence in chronic fatigue syndrome<ref name="Kujawski2021">{{Cite journal | title = Network Analysis of Symptoms Co-Occurrence in Chronic Fatigue Syndrome | date = Jan 2021|url=https://www.mdpi.com/1660-4601/18/20/10736|journal=International Journal of Environmental Research and Public Health|volume=18|issue=20|pages=10736 | last = Kujawski | first = Sławomir | author-link = | last2 = Słomko | first2 = Joanna | authorlink2 = | last3 = Newton | first3 = Julia L. | authorlink3 = Julia Newton | last4 = Eaton-Fitch | first4 = Natalie | author-link4 = Natalie Eaton-Fitch| last5 = Staines | first5 = Donald R. | authorlink5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik | last7 = Zalewski | first7 = Paweł | authorlink7 = Paweł Zalewski|language=en|doi=10.3390/ijerph182010736|pmc=PMC8535251|pmid=34682478|issn=1660-4601|quote=|via=}}</ref> - [https://dx.doi.org/10.3390/ijerph182010736 (Full text)] *2021, Impact of life stressors on myalgic encephalomyelitis/chronic fatigue syndrome symptoms: An australian longitudinal study<ref name="Eaton2021s">{{Cite journal | title = Impact of Life Stressors on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symptoms: An Australian Longitudinal Study | date = Jan 2021|url=https://www.mdpi.com/1660-4601/18/20/10614|journal=International Journal of Environmental Research and Public Health|volume=18|issue=20|pages=10614 | last = Balinas | first = Cassandra | author-link = | last2 = Eaton-Fitch | first2 = Natalie | author-link2 = Natalie Eaton-Fitch | last3 = Maksoud | first3=Rebekah | authorlink3 = | last4 = Staines | first4 = Donald | author-link4 = Donald Staines| last5 = Marshall-Gradisnik | first5 = Sonya | authorlink5 = Sonya Marshall-Gradisnik|language=en|doi=10.3390/ijerph182010614|pmc=PMC8535742|pmid=34682360|access-date=|issn=1660-4601|quote=|via=}}</ref> - [https://dx.doi.org/10.3390/ijerph182010614 (Full text)] *2021, Diffusion tensor imaging reveals neuronal microstructural changes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref name="Thapaliya2021">{{Cite journal | title = Diffusion tensor imaging reveals neuronal microstructural changes in myalgic encephalomyelitis/chronic fatigue syndrome | date = Sep 2021|url=https://onlinelibrary.wiley.com/doi/10.1111/ejn.15413|journal=European Journal of Neuroscience|volume=54|issue=6 | pages = 6214–6228 | last = Thapaliya | first = Kiran | author-link = | last2 = Marshall‐Gradisnik | first2 = Sonya | authorlink2 = Sonya Marshall-Gradisnik | last3 = Staines | first3=Donald | authorlink3 = Donald Staines | last4 = Barnden | first4 = Leighton | author-link4 = Leighton Barnden|language=en|doi=10.1111/ejn.15413|pmc=PMC9291819|pmid=34355438|access-date=|issn=0953-816X|quote=|via=}}</ref> - [https://dx.doi.org/10.1111/ejn.15413 (Full text)] *2021, Characterization of IL-2 Stimulation and TRPM7 Pharmacomodulation in NK Cell Cytotoxicity and Channel Co-Localization with PIP2 in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients<ref name="DuPreez2021t2">{{Cite journal | title = Characterization of IL-2 Stimulation and TRPM7 Pharmacomodulation in NK Cell Cytotoxicity and Channel Co-Localization with PIP2 in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients | date = Jan 2021|url=https://www.mdpi.com/1660-4601/18/22/11879/htm|journal=International Journal of Environmental Research and Public Health|volume=18|issue=22|pages=11879 | last = Du Preez | first = Stanley | author-link = | last2 = Eaton-Fitch | first2 = Natalie | author-link2 = Natalie Eaton-Fitch | last3 = Cabanas | first3=Helene | authorlink3 = Hélène Cabanas | last4 = Staines | first4 = Donald | author-link4 = Donald Staines| last5 = Marshall-Gradisnik | first5 = Sonya | authorlink5 = Sonya Marshall-Gradisnik|language=en|doi=10.3390/ijerph182211879|pmc=PMC8618557|pmid=34831634|access-date=|issn=1660-4601|quote=|via=}}</ref> - [https://dx.doi.org/10.3390/ijerph182211879 (Full text)] *2021, Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome<ref name="Sukocheva2021">{{Cite journal | title = Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome | date = 2021-11-26|url=https://www.sciencedirect.com/science/article/pii/S2090123221002320|journal=Journal of Advanced Research | last = Sukocheva | first=Olga A. | last2 = Maksoud | first2 = Rebekah | last3 = Beeraka | first3=Narasimha M. | last4 = Madhunapantula | first4 = SabbaRao V. | last5 = Sinelnikov | first5 = Mikhail | last6 = Nikolenko | first6 = Vladimir N. | last7 = Neganova | first7 = Margarita E. | last8 = Klochkov | first8 = Sergey G. | last9 = Amjad Kamal | first9 = Mohammad | last10 = Staines | first10 = Donald R | authorlink10 = Donald Staines | last11 = Marshall-Gradisnik | first11 = Sonya | authorlink11 = Sonya Marshall-Gradisnik|language=en|doi=10.1016/j.jare.2021.11.013|pmc=PMC8619886|issn=2090-1232}}</ref> - [https://dx.doi.org/10.1016/j.jare.2021.11.013 (Full text)] *2021, A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome<ref name="Maksoud2021n">{{Cite journal | title = A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome | date = 2021-02-17|url=https://doi.org/10.1186/s12967-021-02742-4|journal=Journal of Translational Medicine|volume=19|issue=1 | pages = 81 | last = Maksoud | first = Rebekah | last2 = Balinas | first2 = Cassandra | last3 = Holden | first3=Sean | last4 = Cabanas | first4 = Hélène | author-link4 = Hélène Cabanas| last5 = Staines | first5 = Donald | author-link5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik|doi=10.1186/s12967-021-02742-4|pmc=PMC7890871|pmid=33596913|issn=1479-5876}}</ref> - [https://dx.doi.org/10.1186/s12967-021-02742-4 (Full text)] *2021, A preliminary investigation of nutritional intake and supplement use in australians with myalgic encephalomyelitis/chronic fatigue syndrome and the implications on health-related quality of life<ref name="Weigel2021">{{Cite journal | title = A preliminary investigation of nutritional intake and supplement use in Australians with myalgic encephalomyelitis/chronic fatigue syndrome and the implications on health-related quality of life | date = 2021-06-07|url=https://foodandnutritionresearch.net/index.php/fnr/article/view/5730|journal=Food & Nutrition Research | last = Weigel | first = Breanna | last2 = Eaton-Fitch | first2 = Natalie | last3 = Passmore | first3 = Rachel | last4 = Cabanas | first4 = Hélène | author-link4 = Hélène Cabanas| last5 = Staines | first5 = Donald | author-link5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik |language=en|doi=10.29219/fnr.v65.5730|pmc=PMC8254462|pmid=34262415|issn=1654-661X}}</ref> - [https://dx.doi.org/10.29219/fnr.v65.5730 (Full text)] *2021, The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP2 and NK cell function in myalgic encephalomyelitis/chronic fatigue syndrome patients<ref name="Eaton2021t3">{{Cite journal | title = The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP2 and NK cell function in myalgic encephalomyelitis/chronic fatigue syndrome patients | date = 2021-07-15|url=https://doi.org/10.1186/s12967-021-02974-4|journal=Journal of Translational Medicine|volume=19|issue=1|pages=306 | last = Eaton-Fitch | first = Natalie | authorlink = Natalie Eaton-Fitch | last2 = Cabanas | first2 = Hélène | author-link2 = Hélène Cabanas | last3 = du Preez | first3 = Stanley | last4 = Staines | first4 = Donald| last5 = Marshall-Gradisnik | first5 = Sonya | authorlink5 = Sonya Marshall-Gradisnik|doi=10.1186/s12967-021-02974-4|pmc=PMC8281618|pmid=34266470|issn=1479-5876}}</ref> - [https://dx.doi.org/10.1186/s12967-021-02974-4 (Full text)] *2021, Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment<ref name="Cabanas2021">{{Cite journal | title = Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment | date = 2021|url=https://www.frontiersin.org/articles/10.3389/fimmu.2021.687806|journal=Frontiers in Immunology|volume=12|issue= | pages = 687806 | last = Cabanas | first=Helene | authorlink = Hélène Cabanas | last2 = Muraki | first2 = Katsuhiko | authorlink2 = | last3 = Eaton-Fitch | first3 = Natalie | authorlink3 = Natalie Eaton-Fitch | last4 = Staines | first4 = Donald Ross | author-link4 = Donald Staines| last5 = Marshall-Gradisnik | first5 = Sonya | authorlink5 = Sonya Marshall-Gradisnik|doi=10.3389/fimmu.2021.687806|pmc=PMC8313851|pmid=34326841|access-date=|issn=1664-3224|quote=|via=}}</ref> - [https://www.frontiersin.org/articles/10.3389/fimmu.2021.687806/full (Full text)] *2021, Systematic Review of Sleep Characteristics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref name="Maksoud2021">{{Cite journal | last = Maksoud | first = Rebekah | authorlink = | last2 = Eaton-Fitch | first2 = Natalie | author-link2 = Natalie Eaton-Fitch | last3 = Matula | first3=Michael | authorlink3 = | last4 = Cabanas | first4 = Hélène | author-link4 = Hélène Cabanas| last5 = Staines | first5 = Donald | author-link5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik | date = May 2021 | title = Systematic Review of Sleep Characteristics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|url=https://www.mdpi.com/2227-9032/9/5/568/htm|journal=Healthcare|language=en|volume=9|issue=5|pages=568|doi=10.3390/healthcare9050568|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://www.mdpi.com/2227-9032/9/5/568/htm (Full text)] * 2020, Health-related quality of life in patients with myalgic encephalomyelitis/chronic fatigue syndrome: an Australian cross-sectional study<ref>{{Cite journal | last = Eaton-Fitch | first = N. | author-link = Natalie Eaton-Fitch | last2 = Johnston | first2 = S.C. | authorlink2 = | last3 = Zalewski | first3 = P. | authorlink3 = | last4 = Staines | first4 = D. | authorlink4 = Donald Staines| last5 = Marshall-Gradisnik | first5 = S. | authorlink5 = Sonya Marshall-Gradisnik | date = 2020-01-22 | title = Health-related quality of life in patients with myalgic encephalomyelitis/chronic fatigue syndrome: an Australian cross-sectional study|url=http://link.springer.com/10.1007/s11136-019-02411-6|journal=Quality of Life Research|language=en|volume=|issue=|pages=|doi=10.1007/s11136-019-02411-6|issn=0962-9343|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://link.springer.com/article/10.1007%2Fs11136-019-02411-6 (Full text)] * 2020, Mapping of pathological change in chronic fatigue syndrome using the ratio of T1- and T2-weighted MRI scans<ref name="Thapaliya2020">{{Cite journal | last = Thapaliya | first = Kiran | author-link = | last2 = Marshall-Gradisnik | first2 = Sonya | authorlink2 = Sonya Marshall-Gradisnik | last3 = Staines | first3=Don | authorlink3 = Donald Staines | last4 = Barnden | first4 = Leighton | author-link4 = Leighton Barnden | date = 2020 | title=Mapping of pathological change in chronic fatigue syndrome using the ratio of T1- and T2-weighted MRI scans|url=https://linkinghub.elsevier.com/retrieve/pii/S2213158220302035|journal=NeuroImage: Clinical|language=en|volume=28|issue=|pages=102366|doi=10.1016/j.nicl.2020.102366|pmc = 7417892|pmid=32777701|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417892/ (Full text)] *2020, A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systematic exertion intolerance disease<ref>{{Cite journal | title = A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease | date = 2020-07-29|url=https://doi.org/10.1186/s12967-020-02452-3|journal=Journal of Translational Medicine|volume=18|issue=1|pages=290 | last = Holden | first = Sean | author-link = | last2 = Maksoud | first2 = Rebekah | authorlink2 = | last3 = Eaton-Fitch | first3 = Natalie | authorlink3 = Natalie Eaton-Fitch | last4 = Cabanas | first4 = Hélène | author-link4 = Hélène Cabanas| last5 = Staines | first5 = Donald | author-link5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik|doi=10.1186/s12967-020-02452-3|pmc=PMC7392668|pmid=32727475|access-date=|issn=1479-5876|quote=|via=}}</ref><ref name="Correction2020">https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02575-7</ref> - [https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02452-3 (Full text)], [https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02575-7 (Correction)] *2019, Epidemiology of paediatric chronic fatigue syndrome in Australia<ref name="Knight2019">{{Cite journal | last = Knight | first = Sarah | last2 = Elders | first2 = Shane | last3 = Rodda | first3 = Jill | last4 = Harvey | first4 = Adrienne| last5 = Lubitz | first5 = Lionel | last6 = Rowe | first6 = Kathy | authorlink6 = Kathy Rowe | last7 = Reveley | first7 = Colette | last8 = Hennel | first8 = Sabine | last9 = Towns | first9 = Susan | last10 = Kozlowska | first10 = Kasia | last11 = Payne | first11 = Donald N | last12 = Marshall-Gradisnik | first12 = Sonya | authorlink12=Sonya Marshall-Gradisnik | last13 = Scheinberg | first13 = Adam | date = 2019-02-23 | title = Epidemiology of paediatric chronic fatigue syndrome in Australia|url=http://adc.bmj.com/lookup/doi/10.1136/archdischild-2018-316450|journal=Archives of Disease in Childhood|language=en|pages=archdischild–2018–316450|doi=10.1136/archdischild-2018-316450|issn=0003-9888}}</ref> - [https://adc.bmj.com/content/early/2019/02/23/archdischild-2018-316450.full (Full text)] *2019, Prevalence and characteristics of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in Poland: a cross-sectional study<ref name="Slomko2019">{{Cite journal | last = Słomko | first = Joanna | author-link = | last2 = Newton | first2 = Julia L | authorlink2 = Julia Newton | last3 = Kujawski | first3 = Sławomir | authorlink3 = | last4 = Tafil-Klawe | first4 = Małgorzata | authorlink4 = | last5 = Klawe | first5 = Jacek | authorlink5 = | last6 = Staines | first6 = Donald | author-link6 = Donald Staines | last7 = Marshall-Gradisnik | first7 = Sonya | authorlink7 = Sonya Marshall-Gradisnik | last8 = Zalewski | first8 = Pawel | authorlink8 = Paweł Zalewski | date = Mar 2019 | title = Prevalence and characteristics of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in Poland: a cross-sectional study|url=http://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2018-023955|journal=BMJ Open|language=en|volume=9|issue=3| pages = e023955|doi=10.1136/bmjopen-2018-023955|issn=2044-6055|pmc=|pmid=30850404|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429942/ (Full text)] *2019, Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients<ref>{{Cite journal | last = Cabanas | first=H. | author-link = Hélène Cabanas | last2 = Muraki | first2 = K. | authorlink2 = | last3 = Balinas | first3=C. | authorlink3 = | last4 = Eaton-Fitch | first4 = N. | authorlink4 = Natalie Eaton-Fitch| last5 = Staines | first5 = D. | authorlink5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = S. | authorlink6 = Sonya Marshall-Gradisnik | date = Dec 2019 | title = Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients|url=https://molmed.biomedcentral.com/articles/10.1186/s10020-019-0083-4|journal=Molecular Medicine|language=en|volume=25|issue=1|pages=|doi=10.1186/s10020-019-0083-4|issn=1076-1551|quote=|via=|pmc=|pmid=|access-date=}}</ref> - [https://link.springer.com/article/10.1186/s10020-019-0083-4 (Full text)] *2019, A systematic review of [[Cytokine|cytokines]] in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID)<ref>{{Cite journal | last = Corbitt | first = Matthew | author-link = | last2 = Eaton-Fitch | first2 = Natalie | author-link2 = Natalie Eaton-Fitch | last3 = Staines | first3=Donald | authorlink3 = Donald Staines | last4 = Cabanas | first4 = Hélène | author-link4 = Hélène Cabanas| last5 = Marshall-Gradisnik | first5 = Sonya | authorlink5 = Sonya Marshall-Gradisnik | date = Dec 2019 | title = A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID)|url=https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-019-1433-0|journal=BMC Neurology|language=en|volume=19|issue=1|pages=|doi=10.1186/s12883-019-1433-0|issn=1471-2377|pmc=|pmid=31445522|access-date=|quote=|via=}}</ref> - [https://link.springer.com/article/10.1186/s12883-019-1433-0#citeas (Full text)] * 2019, [[Low dose naltrexone|Naltrexone]] restores impaired transient receptor potential melastatin 3 ion channel function in natural killer cells from myalgic encephalomyelitis/chronic fatigue syndrome patients<ref>{{Cite journal | last = Cabanas | first=Helene | authorlink = Hélène Cabanas | last2 = Muraki | first2 = Katsuhiko | authorlink2 = | last3 = Staines | first3=Donald | authorlink3 = Donald Staines | last4 = Marshall-Gradisnik | first4 = Sonya | authorlink4 = Sonya Marshall-Gradisnik | date = 14 Oct 2019 | title = Naltrexone restores impaired transient receptor potential melastatin 3 ion channel function in natural killer cells from myalgic encephalomyelitis/chronic fatigue syndrome patients|url=https://www.frontiersin.org/articles/10.3389/fimmu.2019.02545/abstract|journal=Frontiers in Immunology|volume=|issue=|pages=|doi=10.3389/fimmu.2019.02545|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://www.frontiersin.org/articles/10.3389/fimmu.2019.02545/abstract (Abstract)] * 2019, Intra [[brainstem]] connectivity is impaired in chronic fatigue syndrome<ref>{{Cite journal | last = Barnden | first = Leighton R | author-link = Leighton Barnden | last2 = Shan | first2 = Zack Y | authorlink2 = Zack Shan | last3 = Staines | first3=Donald R | authorlink3 = Donald Staines | last4 = Marshall-Gradisnik | first4 = Sonya | authorlink4 = Sonya Marshall-Gradisnik| last5 = Finegan | first5 = Kevin | authorlink5 = | last6 = Ireland | first6 = Timothy | author-link6 = | last7 = Bhuta | first7 = Sandeep | date = 2019 | title=Intra brainstem connectivity is impaired in chronic fatigue syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S2213158219303924|journal=NeuroImage: Clinical|language=en|volume=24|issue=|pages=102045|doi=10.1016/j.nicl.2019.102045|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://www.sciencedirect.com/science/article/pii/S2213158219303924 (Full text)] *2019, [[Transient receptor potential melastatin 2]] channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients<ref name="Balinas2019">{{Cite journal | last = Balinas | first = Cassandra | authorlink = Cassandra Balinas | last2 = Cabanas | first2 = Hélène | author-link2 = Hélène Cabanas | last3 = Staines | first3=Donald | authorlink3 = Donald Staines | last4 = Marshall-Gradisnik | first4 = Sonya | authorlink4 = Sonya Marshall-Gradisnik | date = 2019-12-03 | title = Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients|url=https://doi.org/10.1186/s12967-019-02155-4|journal=Journal of Translational Medicine|volume=17|issue=1 | pages = 401|doi=10.1186/s12967-019-02155-4|issn=1479-5876|pmc = 6891975|pmid=31796045|access-date=|quote=|via=}}</ref> - [https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-019-02155-4 (Full text)] *2018, Decreased Expression of TRPM3 and mAChRM3 in the Small Intestine in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref name="Gradisnik2018">{{Cite journal | last = Marshall-Gradisnik | first = Sonya | authorlink = Sonya Marshall-Gradisnik | last2 = Fretel | first2 = Marshall | author-link2 = | last3 = Eaton | first3=Natalie | authorlink3 = Natalie Eaton-Fitch | last4 = Cabanas | first4 = Helene | author-link4 = Hélène Cabanas| last5 = Balinas | first5 = Cassandra | authorlink5 = Cassandra Balinas | last6 = Gopalan | first6 = Vinod | last7 = Petersen | first7 = Daniel | authorlink7 = Daniel Peterson | last8 = Passmore | first8 = Rachel | last9 = Tang | first9 = Kevin | last10 = Haque | first10 = Mazhar | authorlink10 = | last11 = Lam | first11 = Alfred | authorlink11 = | last12 = Staines | first12 = Donald | authorlink12 = Donald Staines | date = 2018-05-31 | title = Decreased Expression of TRPM3 and mAChRM3 in the Small Intestine in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis|url=http://www.scirp.org/journal/PaperInformation.aspx?PaperID=85005&#abstract|journal=International Journal of Clinical Medicine|language=en|volume=09|issue=05 | pages = 467|doi=10.4236/ijcm.2018.95040|via=|pmc=|pmid=|quote=|access-date=}}</ref> - [http://file.scirp.org/Html/11-2101759_85005.htm (Full text)] *2018, [[Brain]] function characteristics of [[chronic fatigue syndrome]]: A task fMRI study<ref name="Shan, 2018" /> - [https://www.sciencedirect.com/science/article/pii/S2213158218301347 (Full Text)] *2018, A Systematic Review of [[Probiotic]] Interventions for Gastrointestinal Symptoms and [[Irritable bowel syndrome|Irritable Bowel Syndrome]] in [[CFS/ME|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)]]<ref name="Corbitt, 2018" /> - [https://www.ncbi.nlm.nih.gov/pubmed/29464501 (Abstract)] *2018, A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis<ref>{{Cite journal | last = Du Preez | first = S. | author-link = | last2 = Corbitt | first2 = M. | authorlink2 = | last3 = Cabanas | first3=H. | authorlink3 = Hélène Cabanas | last4 = Eaton | first4 = N. | authorlink4 = Natalie Eaton-Fitch| last5 = Staines | first5 = D. | authorlink5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = S. | authorlink6 = Sonya Marshall-Gradisnik | date = 2018-12-20 | title = A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis|url=https://doi.org/10.1186/s13643-018-0909-0|journal=Systematic Reviews|volume=7|issue=1|pages=241|doi=10.1186/s13643-018-0909-0|issn=2046-4053|pmc=|pmid=30572962|quote=|via=|access-date=}}</ref> - [https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-018-0909-0 (Full text)] *2018, [[Rituximab]] impedes [[natural killer cell]] function in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] patients: A pilot in vitro investigation<ref name="Eaton2018R">{{Cite journal | last = Eaton | first = Natalie | authorlink = Natalie Eaton-Fitch | last2 = Cabanas | first2 = Hélène | author-link2 = Hélène Cabanas | last3 = Balinas | first3=Cassandra | authorlink3 = | last4 = Klein | first4 = Anne | author-link4 = | last5 = Staines | first5 = Donald | author-link5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik | date = Dec 2018 | title = Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation|url=https://bmcpharmacoltoxicol.biomedcentral.com/articles/10.1186/s40360-018-0203-8|journal=BMC Pharmacology and Toxicology|language=en|volume=19|issue=1|pages=12|doi=10.1186/s40360-018-0203-8|issn=2050-6511|pmc=5870391|pmid=29587879|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870391/ (Full Text)] *2018, Reduced glycolytic reserve in isolated [[natural killer cell]]s from [[ME/CFS|Myalgic encephalomyelitis/chronic fatigue syndrome]] patients: A preliminary investigation<ref name="Nguyen, 2018" /> - [https://www.ncbi.nlm.nih.gov/pubmed/29981562 (Abstract)] *2018, Hyperintense sensorimotor T1 spin echo [[MRI]] is associated with brainstem abnormality in [[chronic fatigue syndrome]]<ref>{{Cite journal | last = Barnden | first = Leighton R. | last2 = Shan | first2 = Zack Y. | last3 = Staines | first3=Donald R. | authorlink3 = Donald Staines | last4 = Marshall-Gradisnik | first4 = Sonya | authorlink4 = Sonya Marshall-Gradisnik| last5 = Finegan | first5 = Kevin | last6 = Ireland | first6 = Timothy | last7 = Bhuta | first7 = Sandeep | date = 2018 | title=Hyperintense sensorimotor T1 spin echo MRI is associated with brainstem abnormality in chronic fatigue syndrome|url=https://www.sciencedirect.com/science/article/pii/S2213158218302237|journal=NeuroImage: Clinical|volume=20|pages=102-109|doi=10.1016/j.nicl.2018.07.011|via=}}</ref> - [https://www.sciencedirect.com/science/article/pii/S2213158218302237 (Full Text)] *2018, Loss of Transient Receptor Potential Melastatin 3 ion channel function in [[Natural killer cell|natural killer cells]] from [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] patients<ref>{{Cite journal | last = Cabanas | first=Hélène | last2 = Muraki | first2 = Katsuhiko | last3 = Eaton | first3=Natalie | last4 = Balinas | first4 = Cassandra| last5 = Staines | first5 = Donald | author-link5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik | date = 2018-08-14 | title = Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients|url=https://molmed.biomedcentral.com/articles/10.1186/s10020-018-0046-1|journal=Molecular Medicine|language=en|volume=24|issue=1|pages=|doi=10.1186/s10020-018-0046-1|issn=1076-1551|via=|pmc=|pmid=|quote= | author-link = Hélène Cabanas | author-link2 = |access-date= | authorlink3 = | authorlink4 = }}</ref> - [https://molmed.biomedcentral.com/articles/10.1186/s10020-018-0046-1 (Full Text)] *2018, Decreased Connectivity and Increased Blood Oxygenation Level Dependent Complexity in the Default Mode Network in Individuals with Chronic Fatigue Syndrome<ref>{{Cite journal | last = Shan | first = Zack Y. | author-link = | last2 = Finegan | first2 = Kevin | author-link2 = | last3 = Bhuta | first3=Sandeep | authorlink3 = | last4 = Ireland | first4 = Timothy | author-link4 = | last5 = Staines | first5 = Donald R. | authorlink5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = Sonya M. | authorlink6 = Sonya Marshall-Gradisnik | last7 = Barnden | first7 = Leighton R. | authorlink7 = | date = Feb 2018 | title = Decreased Connectivity and Increased Blood Oxygenation Level Dependent Complexity in the Default Mode Network in Individuals with Chronic Fatigue Syndrome | url = |journal=Brain Connectivity|volume=8|issue=1|pages=|doi=10.1089/brain.2017.0549|quote=|via=}}</ref> - [https://www.liebertpub.com/doi/abs/10.1089/brain.2017.0549 (Abstract)] *2017, Dietary and nutrition interventions for the therapeutic treatment of [[ME/CFS|chronic fatigue syndrome/myalgic encephalomyelitis]]: a systematic review<ref>{{Cite journal | last = Campagnolo | first = N. | last2 = Johnston | first2 = S. | last3 = Collatz | first3 = A. | last4 = Staines | first4 = D. | authorlink4 = Donald Staines| last5 = Marshall-Gradisnik | first5 = S. | authorlink5 = Sonya Marshall-Gradisnik | date = 22 Jan 2017 | title = Dietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review | url =http://doi.wiley.com/10.1111/jhn.12435|journal=Journal of Human Nutrition and Dietetics|language=en|volume=30|issue=3|pages=247–259|doi=10.1111/jhn.12435|issn=0952-3871|pmc=|pmid=28111818|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434800/ (Full Text)] *2017, Impaired [[calcium]] mobilization in [[natural killer cell]]s from [[ME/CFS|chronic fatigue syndrome/myalgic encephalomyelitis]] patients is associated with transient receptor potential melastatin 3 ion channels<ref name="Nguyen, 2017" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217865/ (Full Text)] *2017, Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in [[ME/CFS|chronic fatigue syndrome/myalgic encephalomyelitis]] patients<ref name="Nguyen, et al, 2017" /> - [http://apjai-journal.org/wp-content/uploads/2017/07/75-81-AP0771.pdf (Full Text)] *2016, ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56dimCD16+ and CD56brightCD16dim/− [[natural killer cell]]s in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] patients<ref name="Huth, 2016" /> - [http://translational-medicine.biomedcentral.com/articles/10.1186/s12967-016-0859-z (Full Text)] *2016, [[Natural killer cell]]s and single nucleotide polymorphisms of specific ion channels and receptor genes in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="Marshall-Gradisnik,SM 2016" /> - [https://www.dovepress.com/natural-killer-cells-and-single-nucleotide-polymorphisms-of-specific-i-peer-reviewed-fulltext-article-TACG (Full Text)] *2016, A Systematic Review of Drug Therapies for [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref name="Collatz, 2016" /> - [https://www.ncbi.nlm.nih.gov/pubmed/27229907 (Abstract)] *2016, Progressive [[brain]] changes in patients with [[chronic fatigue syndrome]]: A longitudinal MRI study<ref name="Shan, 2016" /> - [https://www.scienceopen.com/document/read?vid=ac2948b6-48d1-4ebd-8f96-3a3c5a57f770 (Full Text)] *2016, [[Regulatory T cell|Regulatory T]], [[Natural killer T cell|natural killer T]] and γδ T cells in [[multiple sclerosis]] and [[ME/CFS|chronic fatigue syndrome/myalgic encephalomyelitis]]: a comparison.<ref name="Ramos, 2016" /> - [http://apjai-journal.org/wp-content/uploads/2016/12/8RegulatoryTnaturalkillerAPJAIVol34No4December2016P300.pdf (Full Text)] *2016, [[Natural killer cell|Killer Cell]] Immunoglobulin-like Receptor Genotype and Haplotype Investigation of [[Natural killer cell|Natural Killer Cell]]s from an Australian Population of [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] Patients<ref name="Huth,TK, 2016" /> - [http://www.la-press.com/redirect_fi...enotype-and-Haplotype-Invest.pdf&fileType=pdf (Full Text)] *2015, A Comparison of [[Cytokine]] Profiles of [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] and [[Multiple Sclerosis]] Patients<ref name="Wong, 2015" /> - [http://file.scirp.org/Html/10-2101204_60764.htm (Full Text)] *2015, [[Cytokines]] in the Cerebrospinal Fluids of Patients with [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref name="Peterson, 2015" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365360/ (Full Text)] *2015, Serum Immune Proteins in Moderate and Severe [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] Patients<ref name="Hardcastle, 09052015" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615236/ (Full Text)] *2015, Longitudinal analysis of immune abnormalities in varying severities of [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] patients<ref name="Hardcastle, 092015" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568602/ (Full Text)] *2015, Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)<ref name="Hardcastle, 2015" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450981/ (Full Text)] *2015, Examination of Single Nucleotide Polymorphisms (SNPs) in Transient Receptor Potential (TRP) Ion Channels in [[Chronic Fatigue Syndrome]] Patients<ref name="Marshall-Gradisnik, 2015" /> - [http://journals.sagepub.com/doi/pdf/10.4137/III.S25147 (Full Text)] *2014, Characterization of [[Natural killer cell|Natural Killer Cell]] Phenotypes in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref name="Huth, 2014" /> - [https://www.omicsonline.org/open-access/characterization-of-natural-killer-cell-phenotypes-in-chronic-fatigue-syndrome-2155-9899.1000223.pdf (Full Text)] *2014, The Role of Adaptive and Innate Immune Cells in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref name="BrenuEW2014" /> - [https://www.researchgate.net/publication/259350347_The_Role_of_Adaptive_and_Innate_Immune_Cells_in_Chronic_Fatigue_Syndrome_Myalgic_Encephalomyelitis (Full Text)] *2014, Analysis of the Relationship between Immune Dysfunction and Symptom Severity in Patients with [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)]]<ref name="Hardcastle, 2014" /> - [https://www.omicsonline.org/open-access/analysis-relationship-immune-dysfunction-symptom-severity-patients-chronic-fatigue-2155-9899.1000190.php?aid=22894 (Full Text)] *2013, The role of clinical guidelines for [[ME/CFS|chronic fatigue syndrome/myalgic encephalomyelitis]] in research settings<ref name="Johnston, 2013" /> - [https://www.tandfonline.com/doi/abs/10.1080/21641846.2013.860779 (Abstract)] *2012, The Effects of Influenza Vaccination on Immune Function<ref>{{cite journal | last1 = Brenu | first1 = Ekua W | author-link1 = Ekua Brenu | last2 = van Driel | first2 = Mieke L | authorlink2 = | last3 = Staines | first3 = Donald R | authorlink3 = Donald Staines | last4 = Kreijkamp-Kaspers | first4 = Sanne | authorlink4 = | last5 = Hardcastle | first5 = Sharni L | author-link5 = Sharni Hardcastle | last6 = Marshall-Gradisnik |first6 = Sonya M | authorlink6 = Sonya Marshall-Gradisnik| title=The Effects of Influenza Vaccination on Immune Function in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis|journal=International Journal of Clinical Medicine|volume=3|issue=6 | page = 544-551| date = 2012 |doi=10.4236/ijcm.2012.36098|url= https://file.scirp.org/pdf/IJCM20120600017_29918208.pdf}}</ref> - [https://file.scirp.org/pdf/IJCM20120600017_29918208.pdf (Full Text)] *2011, Immunological abnormalities as potential [[biomarker]]s in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref>{{Cite journal | last = Brenu | first = Ekua W | authorlink = Ekua Brenu | last2 = van Driel | first2 = Mieke L | authorlink2 = | last3 = Staines | first3=Don R | authorlink3 = Donald Staines | last4 = Ashton | first4 = Kevin J | authorlink4 = | last5 = Ramos | first5 = Sandra B | authorlink5 = Sandra Ramos | last6 = Keane | first6 = James | author-link6 = | last7 = Klimas | first7 = Nancy G | authorlink7 = Nancy Klimas | last8 = Marshall-Gradisnik | first8 = Sonya M | authorlink8 = Sonya Marshall-Gradisnik| date = 2011 | title = Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis|url=http://translational-medicine.biomedcentral.com/articles/10.1186/1479-5876-9-81|journal=Journal of Translational Medicine|language=en|volume=9|issue=1 | pages = 81|doi=10.1186/1479-5876-9-81|issn=1479-5876|pmc=3120691|pmid=21619669|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120691/ (Full Text)]
Summary:
Please make sure your edits are consistent with
MEpedia's guidelines
.
By saving changes, you agree to the
Terms of use
, and you irrevocably agree to release your contribution under the
CC BY-SA 3.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)
Navigation
Navigation
Skip to content
Main page
Browse
Become an editor
Random page
Popular pages
Abbreviations
Glossary
About MEpedia
Links for editors
Contents
Guidelines
Recent changes
Pages in need
Search
Help
Wiki tools
Wiki tools
Special pages
Page tools
Page tools
User page tools
More
What links here
Related changes
Page information
Page logs